Fig. 1From: Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trialRationale and Design of the PRevention of cArdiac Dysfunction during Adjuvant Breast Cancer Therapy (PRADA II) trial: Flow chart. CMR = Cardiovascular magnetic resonance B.i.d = twice a dayBack to article page